GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (HKSE:02877) » Definitions » Construction In Progress

China Shineway Pharmaceutical Group (HKSE:02877) Construction In Progress : HK$209 Mil (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is China Shineway Pharmaceutical Group Construction In Progress?

China Shineway Pharmaceutical Group's quarterly construction in progress declined from Dec. 2023 (HK$129 Mil) to Jun. 2024 (HK$0 Mil) but then increased from Jun. 2024 (HK$0 Mil) to Dec. 2024 (HK$209 Mil).

China Shineway Pharmaceutical Group's annual construction in progress declined from Dec. 2022 (HK$216 Mil) to Dec. 2023 (HK$129 Mil) but then increased from Dec. 2023 (HK$129 Mil) to Dec. 2024 (HK$209 Mil).

China Shineway Pharmaceutical Group Construction In Progress Historical Data

The historical data trend for China Shineway Pharmaceutical Group's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group Construction In Progress Chart

China Shineway Pharmaceutical Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 136.91 159.39 215.59 128.72 208.74

China Shineway Pharmaceutical Group Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.59 - 128.72 - 208.74

China Shineway Pharmaceutical Group Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

China Shineway Pharmaceutical Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (HKSE:02877) » Definitions » Construction In Progress
Comparable Companies
HKSE:02561 HKSE:01349 HKSE:06896 HKSE:03613 HKSE:00460 HKSE:02186 HKSE:01681 HKSE:01061 HKSE:02633 HKSE:02005 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
CSWYY:USA C1S:Germany
Address
Luan Cheng, Hebei Province, Shijiazhuang, CHN
Website
https://www.shineway.com.hk
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
Executives
Bh Corporate Services Ltd 2301 Trustee
Bodnar-horvath Kwai Yung Helen 2202 Interest of your spouse
Bodnar-horvath Nicholas Eugene Francis 2201 Interest of corporation controlled by you
Forway Investment Limited 2101 Beneficial owner
Li Zhenjiang 2307 Founder of a discretionary trust who can infl

China Shineway Pharmaceutical Group Headlines

No Headlines